Literature DB >> 35371861

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF).

Riya R Parikh1, Khushbu R Patel1, Joseph V Pergolizzi2, Frank Breve1, Peter Magnusson3,4.   

Abstract

In this review, we evaluated the literature on the benefits and deleterious effects of digoxin in heart failure (HF) with reduced ejection fraction (EF). Although digoxin was considered an effective treatment for HF, the supporting evidence is conflicting. Before the conventional use of modern HF therapies, digoxin was widely used for symptomatic relief on these patients. Further randomized trials are required to reach a definite conclusion about its efficacy and safety in patients experiencing HF with a reduced EF (HFrEF).
Copyright © 2022, Parikh et al.

Entities:  

Keywords:  cardiovascular; cv; digitalis; digoxin; heart failure; hfref; mortality; readmission; reduced ejection fraction; rehospitalization

Year:  2022        PMID: 35371861      PMCID: PMC8971068          DOI: 10.7759/cureus.22778

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  24 in total

1.  Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

Authors:  Sameer Ather; Leif E Peterson; Vijay G Divakaran; Anita Deswal; Kumudha Ramasubbu; Irakli Giorgberidze; Alvin Blaustein; Xander H T Wehrens; Douglas L Mann; Biykem Bozkurt
Journal:  Int J Cardiol       Date:  2010-05-15       Impact factor: 4.164

Review 2.  Is foxglove effective in heart failure?

Authors:  Parminder S Chaggar; Steven M Shaw; Simon G Williams
Journal:  Cardiovasc Ther       Date:  2015-08       Impact factor: 3.023

3.  Effect of digitalis level on readmission and mortality rate among heart failure reduced ejection fraction patients.

Authors:  Hassan Alkhawam; Elsayed Abo-Salem; Feras Zaiem; James Ampadu; Aleef Rahman; Samian Sulaiman; Anwar Zaitoun; Tarek Helmy; Timothy J Vittorio
Journal:  Heart Lung       Date:  2018-08-30       Impact factor: 2.210

4.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

Authors:  Theresa A McDonagh; Marco Metra; Marianna Adamo; Roy S Gardner; Andreas Baumbach; Michael Böhm; Haran Burri; Javed Butler; Jelena Čelutkienė; Ovidiu Chioncel; John G F Cleland; Andrew J S Coats; Maria G Crespo-Leiro; Dimitrios Farmakis; Martine Gilard; Stephane Heymans; Arno W Hoes; Tiny Jaarsma; Ewa A Jankowska; Mitja Lainscak; Carolyn S P Lam; Alexander R Lyon; John J V McMurray; Alexandre Mebazaa; Richard Mindham; Claudio Muneretto; Massimo Francesco Piepoli; Susanna Price; Giuseppe M C Rosano; Frank Ruschitzka; Anne Kathrine Skibelund
Journal:  Eur Heart J       Date:  2021-09-21       Impact factor: 29.983

5.  Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial.

Authors:  Andrew P Ambrosy; Ankeet S Bhatt; Amanda L Stebbins; Lisa M Wruck; Marat Fudim; Stephen J Greene; William E Kraus; Christopher M O'Connor; Ileana L Piña; David J Whellan; Robert J Mentz
Journal:  Am Heart J       Date:  2018-02-11       Impact factor: 4.749

6.  Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Authors:  Awais Malik; Ravi Masson; Steven Singh; Wen-Chih Wu; Milton Packer; Bertram Pitt; Finn Waagstein; Charity J Morgan; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  J Am Coll Cardiol       Date:  2019-08-06       Impact factor: 24.094

7.  Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.

Authors:  Phillip H Lam; Milton Packer; Gauravpal S Gill; Wen-Chih Wu; Wayne C Levy; Michael R Zile; Vijaywant Brar; Cherinne Arundel; Yan Cheng; Steven N Singh; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Med       Date:  2020-04-06       Impact factor: 5.928

Review 8.  Use of Inotropic Agents in Treatment of Systolic Heart Failure.

Authors:  Sohaib Tariq; Wilbert S Aronow
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

9.  Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction.

Authors:  Jingmin Zhou; Juan Cao; Xuejuan Jin; Jun Zhou; Zhenyue Chen; Dingli Xu; Xinchun Yang; Wei Dong; Liwen Li; Yuyuan Fan; Li Chen; Qiaoqing Zhong; Micheal Fu; Kai Hu; Junbo Ge
Journal:  ESC Heart Fail       Date:  2020-01-29

Review 10.  Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.

Authors:  Oliver J Ziff; Deirdre A Lane; Monica Samra; Michael Griffith; Paulus Kirchhof; Gregory Y H Lip; Richard P Steeds; Jonathan Townend; Dipak Kotecha
Journal:  BMJ       Date:  2015-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.